Compare Stocks: HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALAB Astera Labs	$359.86 +1.1%	$307.27	$97.89 ▼ $499.48	$62.28B	3.77	5.18 million shs	958,541 shs
FVRR Fiverr International	$8.57 -0.5%	$9.21	$8.31 ▼ $24.39	$307.01M	1.44	990,094 shs	78,563 shs
HIMS Hims & Hers Health	$29.22 -1.9%	$29.33	$13.74 ▼ $65.30	$6.80B	2.42	23.71 million shs	2.70 million shs
LLY Eli Lilly and Company	$1,149.47 -0.7%	$1,178.06	$783.85 ▼ $1,292.65	$1.08T	0.5	2.98 million shs	449,774 shs
NVO Novo Nordisk A/S	$37.55 -0.9%	$45.08	$35.12 ▼ $64.16	$167.49B	0.74	17.05 million shs	3.04 million shs
PAYO Payoneer Global	$7.15 +0.1%	$7.13	$4.08 ▼ $7.19	$2.42B	0.94	4.93 million shs	89,886 shs
UPWK Upwork	$8.19 +0.3%	$8.77	$7.44 ▼ $22.84	$1.02B	1.01	3.64 million shs	534,567 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALAB Astera Labs	-0.52%	-1.25%	+19.86%	-12.41%	+81.80%
FVRR Fiverr International	+1.00%	+1.11%	-8.92%	-20.15%	-64.81%
HIMS Hims & Hers Health	+3.87%	+4.68%	+0.68%	-19.01%	-47.52%
LLY Eli Lilly and Company	-1.95%	+0.70%	+0.10%	-3.86%	+52.26%
NVO Novo Nordisk A/S	-1.02%	-0.70%	-16.36%	-24.74%	-31.70%
PAYO Payoneer Global	+0.07%	+0.07%	+0.49%	+0.78%	+18.10%
UPWK Upwork	+0.74%	-0.24%	-9.63%	-10.92%	-56.06%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALAB Astera Labs	$359.86 +1.1%	$307.27	$97.89 ▼ $499.48	$62.28B	3.77	5.18 million shs	958,541 shs
FVRR Fiverr International	$8.57 -0.5%	$9.21	$8.31 ▼ $24.39	$307.01M	1.44	990,094 shs	78,563 shs
HIMS Hims & Hers Health	$29.22 -1.9%	$29.33	$13.74 ▼ $65.30	$6.80B	2.42	23.71 million shs	2.70 million shs
LLY Eli Lilly and Company	$1,149.47 -0.7%	$1,178.06	$783.85 ▼ $1,292.65	$1.08T	0.5	2.98 million shs	449,774 shs
NVO Novo Nordisk A/S	$37.55 -0.9%	$45.08	$35.12 ▼ $64.16	$167.49B	0.74	17.05 million shs	3.04 million shs
PAYO Payoneer Global	$7.15 +0.1%	$7.13	$4.08 ▼ $7.19	$2.42B	0.94	4.93 million shs	89,886 shs
UPWK Upwork	$8.19 +0.3%	$8.77	$7.44 ▼ $22.84	$1.02B	1.01	3.64 million shs	534,567 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALAB Astera Labs	-0.52%	-1.25%	+19.86%	-12.41%	+81.80%
FVRR Fiverr International	+1.00%	+1.11%	-8.92%	-20.15%	-64.81%
HIMS Hims & Hers Health	+3.87%	+4.68%	+0.68%	-19.01%	-47.52%
LLY Eli Lilly and Company	-1.95%	+0.70%	+0.10%	-3.86%	+52.26%
NVO Novo Nordisk A/S	-1.02%	-0.70%	-16.36%	-24.74%	-31.70%
PAYO Payoneer Global	+0.07%	+0.07%	+0.49%	+0.78%	+18.10%
UPWK Upwork	+0.74%	-0.24%	-9.63%	-10.92%	-56.06%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALAB Astera Labs	2.67	Moderate Buy	$348.33	-3.20% Downside
FVRR Fiverr International	1.92	Reduce	$12.56	46.54% Upside
HIMS Hims & Hers Health	2.13	Hold	$32.43	10.99% Upside
LLY Eli Lilly and Company	2.87	Moderate Buy	$1,311.96	14.14% Upside
NVO Novo Nordisk A/S	2.07	Hold	$102.85	173.90% Upside
PAYO Payoneer Global	2.11	Hold	$7.40	3.57% Upside
UPWK Upwork	2.15	Hold	$13.05	59.44% Upside

Current Analyst Ratings Breakdown

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/29/2026	FVRR Fiverr International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
9/29/2026	NVO Novo Nordisk A/S	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform
9/29/2026	NVO Novo Nordisk A/S	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell
9/28/2026	LLY Eli Lilly and Company	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$1,400.00 ➝ $1,500.00
9/22/2026	LLY Eli Lilly and Company	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$1,250.00
9/22/2026	NVO Novo Nordisk A/S	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Sell	$38.00
9/21/2026	NVO Novo Nordisk A/S	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/21/2026	NVO Novo Nordisk A/S	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/21/2026	NVO Novo Nordisk A/S	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
9/21/2026	NVO Novo Nordisk A/S	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
9/18/2026	LLY Eli Lilly and Company	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$1,273.00 ➝ $1,284.00

(Data available from 10/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALAB Astera Labs	$852.53M	73.23	$1.21 per share	297.02	$8.07 per share	44.59
FVRR Fiverr International	$430.91M	0.72	$2.52 per share	3.40	$11.49 per share	0.75
HIMS Hims & Hers Health	$2.35B	2.90	$0.85 per share	34.29	$2.38 per share	12.28
LLY Eli Lilly and Company	$79.67B	13.58	$24.39 per share	47.12	$28.07 per share	40.95
NVO Novo Nordisk A/S	$46.80B	3.58	$4.60 per share	8.17	$6.58 per share	5.71
PAYO Payoneer Global	$1.05B	2.30	$0.40 per share	17.93	$2.02 per share	3.54
UPWK Upwork	$787.78M	1.30	$1.05 per share	7.79	$4.83 per share	1.69

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALAB Astera Labs	$219.13M	$2.02	177.71	78.57	N/A	30.74%	19.24%	17.27%	11/3/2026 (Estimated)
FVRR Fiverr International	$20.98M	$0.81	10.54	15.59	N/A	7.18%	16.14%	8.37%	11/4/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.63	N/A	66.42	N/A	-5.51%	-6.51%	-1.20%	11/9/2026 (Estimated)
LLY Eli Lilly and Company	$20.64B	$29.80	38.65	24.59	1.45	33.53%	97.83%	23.23%	10/29/2026 (Estimated)
NVO Novo Nordisk A/S	$15.51B	$4.09	9.17	10.98	1.26	35.36%	58.61%	20.91%	11/4/2026 (Estimated)
PAYO Payoneer Global	$73.19M	$0.14	51.04	23.05	1.83	4.65%	9.97%	0.80%	11/4/2026 (Estimated)
UPWK Upwork	$115.43M	$0.77	10.63	N/A	N/A	12.94%	16.70%	7.94%	11/2/2026 (Estimated)

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/29/2026	Q3 2026	LLY Eli Lilly and Company	$9.92	N/A	N/A	N/A	$22.32 billion	N/A
8/10/2026	Q2 2026	HIMS Hims & Hers Health	-$0.0498	-$0.37	-$0.3202	-$0.37	$698.90 million	$753.21 million
8/10/2026	Q2 2026	UPWK Upwork	$0.3424	$0.41	+$0.0676	$0.20	N/A	$191.66 million
8/6/2026	Q2 2026	PAYO Payoneer Global	$0.0576	-$0.01	-$0.0676	-$0.01	$270.98 million	$274.26 million
8/5/2026	Q2 2026	LLY Eli Lilly and Company	$6.40	$8.38	+$1.98	$7.94	$20.82 billion	$22.97 billion
8/5/2026	Q2 2026	NVO Novo Nordisk A/S	$0.77	$0.96	+$0.19	$0.72	$10.89 billion	$11.98 billion
8/4/2026	Q2 2026	ALAB Astera Labs	$0.6910	$0.80	+$0.1090	$0.83	$360.85 million	$392.40 million
7/29/2026	Q2 2026	FVRR Fiverr International	$0.52	$0.50	-$0.02	$0.12	$99.46 million	$97.78 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALAB Astera Labs	N/A	N/A	N/A	N/A	N/A
FVRR Fiverr International	N/A	N/A	N/A	N/A	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.92	0.60%	+15.18%	23.22%	11 Years
NVO Novo Nordisk A/S	$0.82	2.16%	+21.74%	20.05%	N/A
PAYO Payoneer Global	N/A	N/A	N/A	N/A	N/A
UPWK Upwork	N/A	N/A	N/A	N/A	N/A

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/5/2026	NVO Novo Nordisk A/S		$0.5786	2.58%	8/17/2026	8/17/2026	8/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALAB Astera Labs	N/A	10.05	9.36
FVRR Fiverr International	N/A	1.82	1.82
HIMS Hims & Hers Health	4.21	0.93	0.87
LLY Eli Lilly and Company	1.41	1.35	1.00
NVO Novo Nordisk A/S	0.55	0.87	0.66
PAYO Payoneer Global	N/A	1.00	1.00
UPWK Upwork	N/A	1.42	1.42

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALAB Astera Labs	60.47%
FVRR Fiverr International	59.00%
HIMS Hims & Hers Health	63.52%
LLY Eli Lilly and Company	82.53%
NVO Novo Nordisk A/S	11.54%
PAYO Payoneer Global	82.22%
UPWK Upwork	77.71%

Insider Ownership

Company	Insider Ownership
ALAB Astera Labs	10.40%
FVRR Fiverr International	15.90%
HIMS Hims & Hers Health	11.76%
LLY Eli Lilly and Company	0.14%
NVO Novo Nordisk A/S	0.07%
PAYO Payoneer Global	2.06%
UPWK Upwork	4.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALAB Astera Labs	756	173.49 million	155.44 million	Optionable
FVRR Fiverr International	528	35.95 million	30.24 million	Optionable
HIMS Hims & Hers Health	2,442	233.31 million	205.88 million	Optionable
LLY Eli Lilly and Company	50,000	941.36 million	940.04 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
PAYO Payoneer Global	2,540	338.85 million	331.87 million	Optionable
UPWK Upwork	630	124.90 million	118.78 million	Optionable

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Headlines

Recent News About These Companies

704,083 Shares in Upwork Inc. $UPWK Purchased by Bank of America Corp DE

September 28 at 3:19 AM | marketbeat.com

Il CEO di Upwork Hayden Brown vende azioni UPWK per $201.917

September 27, 2026 | it.investing.com

Upwork (UPWK)

September 25, 2026 | es.investing.com

Upwork (NASDAQ:UPWK) CAO Sells $10,976.55 in Stock

September 25, 2026 | americanbankingnews.com

Erica Gessert Sells 9,336 Shares of Upwork (NASDAQ:UPWK) Stock

September 24, 2026 | americanbankingnews.com

Hayden Brown Sells 23,893 Shares of Upwork (NASDAQ:UPWK) Stock

September 24, 2026 | americanbankingnews.com

Anthony Ray Kappus Sells 45,732 Shares of Upwork (NASDAQ:UPWK) Stock

September 24, 2026 | americanbankingnews.com

Sabrina Mekhalfa Sells 1,299 Shares of Upwork (NASDAQ:UPWK) Stock

September 23, 2026 | insidertrades.com

Upwork stock slips as earnings beat meets revenue decline

September 22, 2026 | ad-hoc-news.deA

Upwork (NASDAQ:UPWK) CAO Sabrina Mekhalfa Sells 1,299 Shares of Stock

September 22, 2026 | marketbeat.com

Insider Selling: Upwork (NASDAQ:UPWK) CFO Sells $78,889.20 in Stock

September 22, 2026 | marketbeat.com

Upwork (NASDAQ:UPWK) CEO Hayden Brown Sells 23,893 Shares

September 22, 2026 | marketbeat.com

Insider Selling: Upwork (NASDAQ:UPWK) COO Sells 45,732 Shares of Stock

September 22, 2026 | marketbeat.com

Upwork stock falls after profit beat and guidance cut

September 20, 2026 | ad-hoc-news.deA

What is Upwork? A Thorough Explanation of Pros and Cons by Someone Earning 10 Million Yen Annually [How to Start and Points to Note]

September 19, 2026 | note.comN

Upwork (UPWK), Why Is The Market Taking A Closer Look?

September 18, 2026 | finance.yahoo.com

Upwork Inc. (NASDAQ:UPWK) Receives Average Rating of "Hold" from Analysts

September 18, 2026 | marketbeat.com

2 Internet Stocks for Long-Term Investors and 1 We Question

September 15, 2026 | finance.yahoo.com

Upwork Inc. $UPWK Shares Sold by SkyView Investment Advisors LLC

September 15, 2026 | marketbeat.com

Upwork Inc. $UPWK Shares Bought by Engineers Gate Manager LP

September 15, 2026 | marketbeat.com

Upwork Inc. (UPWK) Stock Price, News, Quote & History - Yahoo Finance

September 15, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Company Descriptions

Astera Labs NASDAQ:ALAB

$359.86 +3.89 (+1.09%)

As of 10:59 AM Eastern

Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. The company was incorporated in 2017 and is based in Santa Clara, California.

Fiverr International NYSE:FVRR

$8.57 -0.05 (-0.55%)

As of 10:59 AM Eastern

Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes various categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers value-added products, including subscription-based content marketing, back-office, learning and development offerings, creative talent, and freelancer management platforms. In addition, the company provides a suite of professional solutions that enable businesses to engage with freelancers; Fiverr Pro, a marketplace; Fiverr Certified, a storefront to access certified experts for partner vendors; Fiverr Enterprise, a gateway to source and manage on-demand and long-term freelancers. Further, it offers various value-added products, including Promoted Gigs which allows sellers to advertise their services on the platform; and Seller Plus, a subscription program that equips sellers with advanced tools. The company's buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and agencies. Fiverr International Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

Hims & Hers Health NYSE:HIMS

$29.22 -0.57 (-1.90%)

As of 10:59 AM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Eli Lilly and Company NYSE:LLY

$1,149.47 -7.61 (-0.66%)

As of 10:59 AM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S NYSE:NVO

$37.55 -0.36 (-0.94%)

As of 10:59 AM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Payoneer Global NASDAQ:PAYO

$7.14 +0.01 (+0.07%)

As of 10:59 AM Eastern

Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York.

Upwork NASDAQ:UPWK

$8.18 +0.03 (+0.31%)

As of 10:59 AM Eastern

Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including administrative support, sales and marketing, design and creative, and customer service, as well as web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Payroll and Upwork Enterprise, as well as managed and escrow services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Earnings

Compare Dividends

Latest HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, LLY, NVO, PAYO, UPWK, FVRR, and ALAB Company Descriptions

Astera Labs NASDAQ:ALAB

Fiverr International NYSE:FVRR

Hims & Hers Health NYSE:HIMS

Eli Lilly and Company NYSE:LLY

Novo Nordisk A/S NYSE:NVO

Payoneer Global NASDAQ:PAYO

Upwork NASDAQ:UPWK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools